Nachweis Nichtbiologischer Störungen durch Implantierbare Medizinische Vorrichtung

EP4725404 15. April 2026

Anmelder: Pacesetter, Inc. 🇺🇸

Details

Veröffentlichungs-Nr.
EP4725404
Anmeldetag
27. Februar 2025
Veröffentlichung
15. April 2026
Rechtsraum
EP
IPC
A61B5/00
Offizieller Volltext

Abstract

An implantable medical device (IMD) (101, 501) is described herein. The IMD (101, 501) includes sense circuitry (116, 544, 550) configured to produce a differential signal indicative of a voltage potential difference between first and second electrodes (112, 114). The IMD (101, 501) additionally includes disturbance detection circuitry (210) configured to detect a non-biological disturbance based at least in part on a slew rate of the differential signal exceeding a slew rate threshold. The IMD (101, 501) includes a controller (120, 520) communicatively coupled to the sense circuitry (116, 544, 550) and the disturbance detection circuitry (210) and configured to detect based on the differential signal an episode of asystole, an episode sinus pause, a premature ventricular contraction, or premature atrial contraction, and classify, as a false positive, a detection of the episode of asystole, the episode sinus pause, the premature ventricular contraction, or the premature atrial contraction, when the non-biological disturbance detected by the disturbance detection circuitry (210) at least partially coincides with the detection of the episode of asystole, the episode sinus pause, the premature ventricular contraction, or the premature atrial contraction.

Anmelder

Firma
Pacesetter, Inc.
Land
🇺🇸 USA
🇺🇸 Pacesetter

US-amerikanisches Unternehmen der Medizintechnik, historisch Hersteller von Herzschrittmachern und implantierbaren Defibrillatoren, später Teil von Abbotts Herzrhythmus-Sparte.

196 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen